Elixxer Ltd. (ELIXF) Research

Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.

Market snapshot

Symbol
ELIXF
Price
$0.03
Day change
0.00%
Market cap
$33.1M
P/E ratio
-0.14x
52-week range
0.0013-0.0991
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Next earnings
in 2 days

Peer companies

  • Atlas Energy Corp. (CANSF)
  • C21 Investments Inc. (CXXIF)
  • BellRock Brands Inc. (DXBRF)
  • Flower One Holdings Inc. (FLOOF)
  • 1CM Inc. (MILFF)
  • MariMed Inc. (MRMD)
  • Sunniva Inc. (SNNVF)
  • Speakeasy Cannabis Club Ltd. (SPBBF)

Open Elixxer Ltd. (ELIXF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.